| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.3 | 4e-10 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.29 | 2e-09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-11 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |